Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

CAPS Rating: 3 out of 5

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.

Recs

0
Player Avatar pchop123 (79.50) Submitted: 11/8/2012 7:43:01 PM : Outperform Start Price: $40.94 SLXP Score: -5.24

should have good EPS this month

Featured Broker Partners


Advertisement